Badar, T., Kettani, M. E., shah, K., Jamy, O. H., Shallis, R., Diebold, K., Coltoff, A., Goldberg, A. D., Patel, A. A., Bewersdorf, J. P., Foucar, C., Abaza, Y., Palmisiano, N., Duvall, A., Kota, V., Zeidan, A. M., Atallah, E. L., Litzow, M. R. (2025). Should we treat TP53-mutated high-risk myeloid neoplasms in older patients?. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.6538